(Q37332201)

19 August 2017

1 reference

title

Complications of hemophilia A treatment: factor VIII inhibitors (English)

1 reference

19 August 2017

0 references

Coagulation factor VIII

0 references

hemophilia A

0 references

author name string

Kasper CK

series ordinal

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 January 1991

1 reference

Annals of the New York Academy of Sciences

19 August 2017

published in

1 reference

19 August 2017

volume

614

1 reference

19 August 2017

page(s)

97-105

1 reference

Detection and sequence of mutations in the factor VIII gene of haemophiliacs

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Disappearance of inhibitor to factor VIII in HIV-infected hemophiliacs with progression to AIDS or severe ARC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

The Treatment of Patients who have Factor-VIII Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Anti-idiotypic suppression of antibodies to factor VIIIc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Anti-idiotypes to factor VIII antibodies and their possible role in the pathogenesis and treatment of factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB43695.X

10.1111/J.1749-6632.1991.TB43695.X

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference